BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating ...

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

Cassava's financial challenges and data integrity concerns remain critical. Learn why SAVA stock is rated a strong sell given ...

FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, ...

CluePoints has announced the launch of its latest application, Medical & Safety Review (MSR), designed to revolutionize the ...

A meta-analysis reveals gamified digital mental health interventions effectively reduce depression and ADHD in youth, ...

Similarly, TransCelerate’s Comparator Network (CN) Initiative, which aims to enhance patient safety by establishing a reliable mechanism to acquire clinical trial comparator and co-therapy drugs ...

New 56-week data from an interim analysis of the phase III ARCADIA long-term extension study will be presented, with nemolizumab demonstrating a ...

Dr. Gopakumar Iyer discussed how to Integrate Novel Therapeutics with trimodal therapy (TMT). Radiation therapy (RT) has ...

Background Healthcare-associated infections due to multidrug-resistant organisms (MDROs) remain a high priority patient ...